References
- Holland JF. Cancer medicine. Lea & Febiger, Philadelphia 1993
- Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007; 242: 555–62
- Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 1956; 76: 988–1000
- Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res 2007; 67: 3970–5
- Guess B, Jennrich R, Johnson H, Redheffer R, Scholz M. Using splines to detect changes in PSA doubling times. Prostate 2003; 54: 88–94
- Nishida K, Kaneko T, Yoneda M, Nakagawa S, Ishikawa T, Yamane E, et al. Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis. J Surg Oncol 1999; 71: 140–6
- Arai T, Kuroishi T, Saito Y, Kurita Y, Naruke T, Kaneko M. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 1994; 24: 199–204
- Kuroishi T, Tominaga S, Morimoto T, Tashiro H, Itoh S, Watanabe H, et al. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res 1990; 81: 454–62
- Balmukhanov SB, Turdugulov I, Karibjanova Z, Revesz L. The growth rate of bone sarcomas and survival after radiotherapy with tourniquet-induced hypoxia: A clinical study. Cancer 1982; 49: 1597–604
- Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 2001; 96: 1877–80
- Duhaylongsod FG, Lowe VJ, Patz EF, Jr, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995; 60: 1348–52
- Tsunoda A, Shibusawa M, Tsunoda Y, Yasuda N, Koike T. Reduced growth rate of dimethylhydrazine-induced colon tumors in rats. Cancer Res 1992; 52: 696–700
- Spratt JS, Jr. The lognormal frequency distribution and human cancer. J Surg Res 1969; 9: 151–7
- Usuda K, Saito Y, Sagawa M, Sato M, Kanma K, Takahashi S, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 1994; 74: 2239–44
- Shackney SE, McCormack GW, Cuchural GJ, Jr. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: An analytical review. Ann Intern Med 1978; 89: 107–21
- Spratt JS, Jr, Spratt TL. Rates of growth of pulmonary metastases and host survival. Ann Surg 1964; 159: 161–71
- Lee JY, Kim CK, Choi D, Park BK. Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: A single-institution experience. Eur Radiol 2008; 18: 731–7
- Satkauskas S, Batiuskaite D, Salomskaite-Davalgiene S, Venslauskas MS. Effectiveness of tumor electrochemotherapy as a function of electric pulse strength and duration. Bioelectrochemistry (Amsterdam Netherlands) 2005; 65: 105–11